These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 15668139)
41. Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus. Chen H; McCarty DM; Bruce AT; Suzuki K J Neurosci Res; 1999 Feb; 55(4):504-13. PubMed ID: 10723060 [TBL] [Abstract][Full Text] [Related]
42. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634 [TBL] [Abstract][Full Text] [Related]
43. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector. Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106 [TBL] [Abstract][Full Text] [Related]
44. No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery. Jakob M; Mühle C; Park J; Weiss S; Waddington S; Schneider H J Gene Med; 2005 May; 7(5):630-7. PubMed ID: 15693035 [TBL] [Abstract][Full Text] [Related]
45. Central CART gene delivery by recombinant AAV vector attenuates body weight gain in diet-induced-obese rats. Qing K; Chen Y Regul Pept; 2007 Apr; 140(1-2):21-6. PubMed ID: 17182122 [TBL] [Abstract][Full Text] [Related]
46. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy. Qi X; Sun L; Lewin AS; Hauswirth WW; Guy J Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5360-70. PubMed ID: 18055782 [TBL] [Abstract][Full Text] [Related]
47. Efficiency of lentiviral transduction during development in normal and rd mice. Pang J; Cheng M; Haire SE; Barker E; Planelles V; Blanks JC Mol Vis; 2006 Jul; 12():756-67. PubMed ID: 16862069 [TBL] [Abstract][Full Text] [Related]
49. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Grieger JC; Samulski RJ Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890 [TBL] [Abstract][Full Text] [Related]
50. Superior Retinal Gene Transfer and Biodistribution Profile of Subretinal Versus Intravitreal Delivery of AAV8 in Nonhuman Primates. Seitz IP; Michalakis S; Wilhelm B; Reichel FF; Ochakovski GA; Zrenner E; Ueffing M; Biel M; Wissinger B; Bartz-Schmidt KU; Peters T; Fischer MD; Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5792-5801. PubMed ID: 29117317 [TBL] [Abstract][Full Text] [Related]
51. Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1. Iwamoto N; Watanabe A; Yamamoto M; Miyake N; Kurai T; Teramoto A; Shimada T J Gene Med; 2009 Jun; 11(6):498-505. PubMed ID: 19338016 [TBL] [Abstract][Full Text] [Related]
52. Retinal cell type expression specificity of HIV-1-derived gene transfer vectors upon subretinal injection in the adult rat: influence of pseudotyping and promoter. Bemelmans AP; Bonnel S; Houhou L; Dufour N; Nandrot E; Helmlinger D; Sarkis C; Abitbol M; Mallet J J Gene Med; 2005 Oct; 7(10):1367-74. PubMed ID: 15966018 [TBL] [Abstract][Full Text] [Related]
53. Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration. Pang JJ; Lauramore A; Deng WT; Li Q; Doyle TJ; Chiodo V; Li J; Hauswirth WW Vision Res; 2008 Feb; 48(3):377-85. PubMed ID: 17950399 [TBL] [Abstract][Full Text] [Related]
54. Gene therapy and transplantation in the retinofugal pathway. Harvey AR; Hellström M; Rodger J Prog Brain Res; 2009; 175():151-61. PubMed ID: 19660654 [TBL] [Abstract][Full Text] [Related]
55. Use of recombinant adeno-associated viral vectors as a tool for labeling bone marrow cells. Iwakura A; Dean J; Hamada H; Eaton E; Qin G; Losordo DW; Aikawa R J Mol Cell Cardiol; 2005 May; 38(5):799-802. PubMed ID: 15850573 [TBL] [Abstract][Full Text] [Related]
57. Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy. Gao Y; Ng SS; Chau DH; Yao H; Yang C; Man K; Huang PT; Huang C; Huang JJ; Kung HF; Lin MC Cancer Gene Ther; 2008 Nov; 15(11):723-32. PubMed ID: 18535618 [TBL] [Abstract][Full Text] [Related]
58. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer. Isayeva T; Ren C; Ponnazhagan S Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207 [TBL] [Abstract][Full Text] [Related]